Digitalizing Biopharma: R&D Innovation through Operational Excellence
Presented at BIO-IT Boston, Virtual Meeting
Sebastian Schlicker, Head, Operations - Biologics Business, Genedata
We present a purpose-built E2E workflow platform that supports, both operationally and scientifically, the entire biopharma R&D process. The platform increases overall process efficiency and quality by integrating and automating workflows and identifying the most promising drug candidates to move forward. We show how the platform enables the exploration of new R&D processes, such as the engineering of highly-engineered multi-specific antibodies and novel cell and gene therapies (CARTs, TCRs).